ADMEトキシコロジーテスト市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global ADME toxicology testing market grew at a CAGR of around 13% during 2015-2020. Absorption, distribution, metabolism and excretion (ADME) toxicology testing is conducted at an early phase ... もっと見る
サマリーThe global ADME toxicology testing market grew at a CAGR of around 13% during 2015-2020. Absorption, distribution, metabolism and excretion (ADME) toxicology testing is conducted at an early phase of the drug development process to determine the safety, uptake, elimination, effectiveness and metabolic behavior of a parent compound or drug in living organisms. It is generally carried out by researchers in cell-based and in vitro assays using software solutions, devices, detectors, etc. to identify active compounds, genetic interactions and other biomolecular interactions. It helps in understanding the safety and toxicity of a drug candidate before progressing it into a late stage preclinical and clinical studies, thereby saving cost, drug discovery time and test complications.The growing prevalence of diseases is increasing the requirement of novels drugs and biological products. This represents one of the key factors escalating the adoption of ADME toxicology testing to prevent the failure of candidate drugs at late-stage clinical trials.111 It also helps researchers to determine the viability of these drugs necessary for regulatory approval. Additionally, one of the key trends witnessed in the market is the introduction of several guidance documents by the Food and Drug Administration (FDA) to provide instruction about ADME properties when evaluating the safety and efficacy of a drug candidate. Apart from this, the introduction of software that can calculate ADME automatically is gaining traction over conventional in vitro assays and in vivo experiments. Furthermore, due to the mass outbreak of the coronavirus disease (COVID-19) and a significant lack of an effective vaccine or treatment, ADME toxicology testing is being utilized to calculate the efficacy of existing drugs as an alternative treatment, which is also augmenting the market growth. Looking forward, IMARC Group expects the global ADME toxicology testing market to exhibit strong growth during the next five years. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global ADME toxicology testing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology, product type, method and application. Breakup by Technology: Cell Culture High Throughput Screening Molecular Imaging OMICS Technology Others Breakup by Product Type: Instruments Software Solutions Assay Systems Reagents Others Breakup by Method: In-Vivo In-Vitro In-Silica Others Breakup by Application: Systemic Toxicity Renal Toxicity Hepatotoxicity Neurotoxicity Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Bioivt LLC, Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Cyprotex Plc (Evotec AG), Molecular Discovery Ltd., Perkinelmer Inc., Promega Corporation and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global ADME toxicology testing market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global ADME toxicology testing market? What are the key regional markets? What is the breakup of the market based on the technology? What is the breakup of the market based on the product type? What is the breakup of the market based on the method? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global ADME toxicology testing market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global ADME Toxicology Testing Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Technology 6.1 Cell Culture 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 High Throughput Screening 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Molecular Imaging 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 OMICS Technology 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Product Type 7.1 Instruments 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Software Solutions 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Assay Systems 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Reagents 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Method 8.1 In-Vivo 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 In-Vitro 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 In-Silica 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Application 9.1 Systemic Toxicity 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Renal Toxicity 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Hepatotoxicity 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Neurotoxicity 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Agilent Technologies Inc. 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Beckman Coulter Inc. (Danaher Corporation) 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 SWOT Analysis 15.3.3 Bioivt LLC 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Bio-Rad Laboratories Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Charles River Laboratories International Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis 15.3.6 Cyprotex Plc (Evotec AG) 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.7 Molecular Discovery Ltd. 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.8 Perkinelmer Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis 15.3.9 Promega Corporation 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.10 Thermo Fisher Scientific Inc. 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis
SummaryThe global ADME toxicology testing market grew at a CAGR of around 13% during 2015-2020. Absorption, distribution, metabolism and excretion (ADME) toxicology testing is conducted at an early phase of the drug development process to determine the safety, uptake, elimination, effectiveness and metabolic behavior of a parent compound or drug in living organisms. It is generally carried out by researchers in cell-based and in vitro assays using software solutions, devices, detectors, etc. to identify active compounds, genetic interactions and other biomolecular interactions. It helps in understanding the safety and toxicity of a drug candidate before progressing it into a late stage preclinical and clinical studies, thereby saving cost, drug discovery time and test complications.The growing prevalence of diseases is increasing the requirement of novels drugs and biological products. This represents one of the key factors escalating the adoption of ADME toxicology testing to prevent the failure of candidate drugs at late-stage clinical trials.111 It also helps researchers to determine the viability of these drugs necessary for regulatory approval. Additionally, one of the key trends witnessed in the market is the introduction of several guidance documents by the Food and Drug Administration (FDA) to provide instruction about ADME properties when evaluating the safety and efficacy of a drug candidate. Apart from this, the introduction of software that can calculate ADME automatically is gaining traction over conventional in vitro assays and in vivo experiments. Furthermore, due to the mass outbreak of the coronavirus disease (COVID-19) and a significant lack of an effective vaccine or treatment, ADME toxicology testing is being utilized to calculate the efficacy of existing drugs as an alternative treatment, which is also augmenting the market growth. Looking forward, IMARC Group expects the global ADME toxicology testing market to exhibit strong growth during the next five years. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global ADME toxicology testing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology, product type, method and application. Breakup by Technology: Cell Culture High Throughput Screening Molecular Imaging OMICS Technology Others Breakup by Product Type: Instruments Software Solutions Assay Systems Reagents Others Breakup by Method: In-Vivo In-Vitro In-Silica Others Breakup by Application: Systemic Toxicity Renal Toxicity Hepatotoxicity Neurotoxicity Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Bioivt LLC, Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Cyprotex Plc (Evotec AG), Molecular Discovery Ltd., Perkinelmer Inc., Promega Corporation and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global ADME toxicology testing market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global ADME toxicology testing market? What are the key regional markets? What is the breakup of the market based on the technology? What is the breakup of the market based on the product type? What is the breakup of the market based on the method? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global ADME toxicology testing market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global ADME Toxicology Testing Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Technology 6.1 Cell Culture 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 High Throughput Screening 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Molecular Imaging 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 OMICS Technology 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Product Type 7.1 Instruments 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Software Solutions 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Assay Systems 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Reagents 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Method 8.1 In-Vivo 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 In-Vitro 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 In-Silica 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Application 9.1 Systemic Toxicity 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Renal Toxicity 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Hepatotoxicity 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Neurotoxicity 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Agilent Technologies Inc. 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 Beckman Coulter Inc. (Danaher Corporation) 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.2.3 SWOT Analysis 15.3.3 Bioivt LLC 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Bio-Rad Laboratories Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Charles River Laboratories International Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.5.3 Financials 15.3.5.4 SWOT Analysis 15.3.6 Cyprotex Plc (Evotec AG) 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.7 Molecular Discovery Ltd. 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.8 Perkinelmer Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.8.4 SWOT Analysis 15.3.9 Promega Corporation 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.10 Thermo Fisher Scientific Inc. 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他(治療を主目的としない薬物))の最新刊レポート
IMARC Services Private Limited.社のその他(治療を主目的としない薬物)分野での最新刊レポート
本レポートと同じKEY WORD(adme)の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |